The DESTINIES Study: an online Delphi study to build international consensus on the medical conditions and procedures that confer immunosuppression and their respective COVID-19 risk profiles
Defining and Risk-Stratifying Immunosuppression (the DESTINIES Study): Protocol for an Electronic Delphi Study
Patients know best: Patient Panel appraisal of a novel, risk-stratified approach to COVID-19 disease surveillance
DESTINIES phenotype extract-ready codelist - Systemized Nomenclature of Medicine Clinical Term (SNOMED-CT) compatible
Access file here
